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SEVERAL recent studies have shown that
hyperthermia is able to enhance the direct
cytotoxic effect of misonidazole (Bleehen
et al., 1978; Hall et al., 1977; Stratford &
Adams, 1977; Stone, 1978). These obser-
vations ledus to investigate the interaction
between radiation, hyperthermia and
misonidazole (MIS) in an attempt toevalu-
ate the role of such multimodality treat-
ment in experimental tumours. During
these experiments we observed an increase
in the acute toxicity to mice when heated
locally in the presence of MIS. Such a
reaction has not previously been de-
scribed, but as it may have implications
for further work in that field, we find it of
importance to report here.
The increased toxicity was initially
observed in mice treated with MIS and
local hyperthermia (43-5°C). In this experi-
ment, 14/37 mice died within 2 days of
treatmentwith 0 5 mg/gMIS, injected i.p.,
30 min before local hyperthermia was
applied to the tumour-bearing leg. Since
this was a considerably higher lethality
rate than was expected, further toxico-
logical studies were initiated.
Ten to twelve-weeks old male and
female C3H/Aa mice bred in our own
colony were used for LD5o/30d assays.
Misonidazole (kindly supplied through
Roche Ltd, Denmark, by courtesy of Rud
Hammer Jensen) was diluted with isotonic
saline to a concentration of 20 mg/ml. This
solution was injected i.p. into non-
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anaesthetized mice 30 min before heating.
Controls were given a similar volume of
isotonic saline only.
For hyperthermic treatment the un-
anaesthetized mice were placed in a
special lucite jig with the right hind limb
taped to a plate allowing it to be immersed
into a water bath heated to 43 5°C. The
water-bath temperature fluctuated less
than 0 10C during treatment. Rectal tem-
perature was measured with a thermo-
couple and recorded on an Ellab T3
thermometer.
The variation in LD50 due to local
hyperthermia is seen in Fig. L. This shows
a significantincrease (P< 0 0005, Wilcoxon
rank correlation test) in acute toxicity of
simultaneous drug application and hyper-
thermia to the animals. The LD50 in this
group was 1-14 mg/g whereas the controls
given the same treatment at room tem-
perature had a LD50 of 1P89 mg/g. The
animals were observed for 30 days, but all
toxic deaths occurred within 2 days of
treatment, mainly with symptoms of
cerebral affection, as shown by unco-
ordinated motoric excitation, ataxia of
hind limbs and convulsions.
Only "simultaneous" treatment (MIS 30
min before hyperthermia) increased
toxicity. Drug given 4 h before or after
heating gave the same LD50 as in the
unheated controls. This is in good agree-
ment with the pharmacokinetics of MIS
in mice, where maximal tumour con-
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FIG. 1.-Effect of local hyperthermia on the
acute lethal toxicity of misonidazole. (0)
Mice heated locally for 60 min at 43 5°C, 30
min after i.p. administration of misonid-
azole. (0) Controls at room temperature.
Each point represents 5-15 animals.
centration is found about 30 min after
i.p. administration, followed by a rapid
elimination with a half-value time of
about 1-5h (Fowler et al., 1976).
The increased death rate may be due to
an influence of the drug on temperature
regulation. Animals heated with the
described technique normally show an
increase in body temperature from 36°C to
about 38 5°C during a 1 h treatment. This
temperature rise occurs mainly within the
first 20 min of the heating, and then
plateaus. In mice given MIS together with
local hyperthermia, the temperature in-
crease was greater, and occurred over the
entire treatment period, reaching an
average temperature close to 41°C (Fig. 2).
Thus, MIS seemed to influence the tem-
perature regulation in mice given a local
hyperthermic treatment.
The increase in temperature apparently
causes the mice to become weak, with
intense sweat production; and several
drug-treated mice died at the end of the
treatment.
The abnormal increase in body tem-
perature was largely independent of the
MIS dose, and no difference was observed
with doses between 0 5 and 2-0 mg/g body
weight. However, mice receiving a dose
of 0-25 mg/g tolerated the treatment
better.
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FIG. 2. Rectal temperature in male mice
locallyheatedwith or withoutmisonidazole.
(0) Animals given 0-75 mg/g misonidazole
30 min before heating. (0) Controls heated
without drug. Vertical bars show s.d. of the
data obtained from 5 animals in each group.
Toxic doses of nitroimidazoles are
known to cause abnormalities in the
temperature regulation in experimental
animals (unpublished information from
drug companies). This is normally ex-
pressed as hypothermia in animals kept
at room temperature. However, if part of
the animal is heated or otherwise exposed
to an elevated temperature, the disorder
in temperature regulation may result in
systemic hyperthermia and death.
The observation that only a simul-
taneous treatment resulted in increased
toxicity may be related to the rapid
absorption and elimination of MIS known
to occur in mice. If a similar hyperthermic
enhancement of acute toxicity occurs in
man, it is likely to be over a greater
interval between drug application and
heating, due to the slower elimination of
MIS in humans (Fowler et at., 1976).
The combined use of MIS and hyper-
thermia has been suggested as a potential
therapy ofhuman tumours (Bleehen et al.,
1978; Johnson, 1978). However, in order
to avoid unexpected side effects, one may
urge caution with such regimens until
further toxicological studies on the inter-
action between hyperthermia and MIS
have been made.
9798 J. OVERGAARD
Supported by the Danish Cancer Society and the
Krista and Viggo Petersen's Foundation.
REFERENCES
BLEEHEN, N. M., HONESS, D. J. & MORGAN, J. E.
(1978) The combined effects of hyperthermia
and hypoxic cell sensitizers. In Cancer Therapy by
Hyperthermia and Radiation. Ed. C. Streffer et al.
Baltimore, Munich: Urban & Schwarzenberg,
p. 62.
FOWLER, J. F., ADAMS, G. E. & DENEKAMP, J. (1976)
Radiosensitizers of hypoxic cells in solid tumours.
Cancer Treat. Rev., 3, 227.
HALL, E. J., ASTOR, M., GEARD, C. & BIAGLOW, J.
(1977) Cytotoxicity of Ro-07-0582; enhancement
by hyperthermia and protection by cvsteamine.
Br. J. Cancer, 35, 809.
JOHNSON, R. J. R. (1978) Radiation and hyper-
thermia. In Cancer Therapy by Hyperthermia and
Radiation. Ed. C. Streffer et al. Baltimore,
Munich: Urban & Schwarzenberg, p. 89.
STONE, H. B. (1978) Enhancement of local tumour
control by Misonidazole and hyperthermia. Br. J.
Cancer, 37 (Suppl. III), 178.
STRATFORD, I. J. & ADAMS, G. E. (1977) Effect of
hyperthermia on differential cytotoxicity of a
hypoxic cell radiosensitizer, Ro-07-0582, on
mammalian cells in vitro. Br. J. Cancer, 35, 307.